AKORN

Dead / Cancelled — Cancelled — Section 8 (as of 29 Jun 2024)

What this means for you

This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number
86937435
Registration number
5076962
Mark type
Stylized text
Filed
11 Mar 2016
Published for opposition
23 Aug 2016
Registered
08 Nov 2016
Attorney of record
Mark A. Paskar

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceutical products and preparations, namely, inhalants, injectables, nasal sprays and mists, oral liquids, oral solids and topicals for sterile aqueous ophthalmic solutions; ocular anesthetics; ophthalmic solutions for the treatment of elevated intraocular pressure in individuals with ocular hypertension or open-angle glaucoma; sterile indocyanine green for use as a cardiac diagnostic aid, a hepatic diagnostic aid and as a retinal diagnostic aid; hypnotic sedative anesthetic compounds; mydriatics; pharmaceutical preparations for the treatment of respiratory conditions; oral analgesics; oral analgesics in solution or liquid form; analgesic preparations; spinal anesthetics; anti-diarrheal agents; schedule III prescription synthetic narcotics; anxiolytics; anti-seizure medications; topical anesthetics; pharmaceutical preparations for treatment of arsenic, gold and mercury poisoning and acute lead poisoning; pharmaceutical preparations for treatment of opioid dependence; antibacterials, namely, antibacterial cleaners, antibacterial hand lotions, and antibacterial pharmaceuticals; pharmaceutical agents for treatment of respiratory ailments, prevention of endometrial hyperplasia and secondary amenorrhea; corticosteroid formulations indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses and musculoskeletal conditions; antiviral agents; anti-infectives; vitamins; dietary and nutritional supplements; magnesium supplements; antacids; pharmaceutical preparations for relief of nasal congestion, sinus pressure and sinus headache, nasal sprays; topicals for the treatment of arthritis, joint pain, back pain, foot pain and muscle pain; preparations for the relief of pain; pain relief medication; arthritis and joint pain preparations; cough suppressants and expectorants; cough drops and syrups; preparations for relief of symptoms of common colds and influenza; tablets, swabs, nasal sprays and effervescent preparations for treating colds and flu; tablets, swabs, nasal sprays and effervescent preparations for preventing colds and flu; medicated foot creams, lotions and ointments; medicated skin creams and lotions, including anti-itch creams; medicated tinctures and ointments for lip and skin care; eye drops; lubricant eye drops; eyelid cleanser, skin care around the eyelid; eye nutrition; contact lens comfort drops, veterinary pharmaceuticals; veterinary pharmaceuticals and preparations, namely, xylazine, ketamine, and reversing agents and antagonists for use in horses; veterinary pain relief medications, anesthetics and sedatives; veterinary ophthalmics; veterinary eye wash; veterinary eye lubricants and eye drops

Owner

Prosecution history

  • 29 Jun 2024 — NOTICE OF CANCELLATION SEC. 8 EMAILED
  • 29 Jun 2024 — CANCELLED SEC. 8 (6-YR)
  • 12 Dec 2023 — POST REGISTRATION ACTION MAILED - SEC. 8
  • 27 Oct 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
  • 21 Sept 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
  • 12 Jul 2023 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
  • 08 May 2023 — TEAS SECTION 8 RECEIVED
  • 22 Feb 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
  • 22 Feb 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 22 Feb 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
  • 22 Feb 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
  • 22 Feb 2022 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
  • 10 Nov 2021 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
  • 08 Nov 2021 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
  • 16 Sept 2021 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

View this trademark record on Marksy